13 Nov 2007 New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models
12 Nov 2007 Major Phase 3 Trial Shows Zevalin(R) Extends Progression-Free Survival in one of the most common types of Lymphoma
09 Nov 2007 Biogen Idec's Baminercept, the First Lymphotoxin-beta Pathway Inhibitor in Development, Shows Promise in Patients with Rheumatoid Arthritis
09 Nov 2007 Human Genome Sciences Reports Positive Data From Long-Term Treatment With LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus
09 Nov 2007 Seattle Genetics Initiates Phase IIb Clinical Trial of SGN-33 in Combination with Chemotherapy for Acute Myeloid Leukemia
08 Nov 2007 Dyax Corp. Announces Extension of Antibody Library Collaboration with ImClone Systems
08 Nov 2007 A Second Overseas Phase III Trial Data Demonstrates Efficacy of "Actemra(R)"
08 Nov 2007 Abbott Research Demonstrates Viability of Combining Antibody Functions to Target Two or More Disease-Causing Processes
08 Nov 2007 Trubion Pharmaceuticals Announces Presentation of Positive Data From Phase IIb and Re-treatment Studies With TRU-015 in Patients With Rheumatoid Arthritis
06 Nov 2007 Micromet's BiTE(R) Antibodies Reveal Unique Mode of Action
06 Nov 2007 Millennium Announces MLN1202 Significantly Reduced Marker of Systemic Inflammation and Identifies Genomic Biomarker For Responders
05 Nov 2007 Positive Results From Peregrine Pharmaceuticals' Bavituximab Phase l HCV Trial Presented at AASLD Meeting
03 Nov 2007 ThromboGenics and BioInvent Announce Publication of Exciting Data on a Novel Class of Angiogenesis I
02 Nov 2007 Seattle Genetics Initiates SGN-40 Clinical Trial in Combination with Revlimid for Multiple Myeloma
01 Nov 2007 Seattle Genetics and MedImmune Expand Antibody-Drug Conjugate Collaboration
30 Oct 2007 Ono and Medarex Announce Allowance of Investigational New Drug Application for Fully Human Anti-PD1 Antibody
29 Oct 2007 Peptech successfully completes Phase I trial for PN0621
26 Oct 2007 Novel Alternative Approach to Inhibiting Insulin Growth Factor (IGF) May Provide New Treatment for Breast Cancer and Other Cancers
26 Oct 2007 Arius announces new findings in Trop-2 and CD59 CANCER antibody programs
25 Oct 2007 Human Genome Sciences presents new data showing anti-tumor activity and safety of trail receptor antibodies in combination with chemotherapy
25 Oct 2007 Milatuzumab Showed Promising Therapeutic Effects Alone and Combined With CD20 Antibody in Preclinical Studies
25 Oct 2007 ImmunoGen, Inc. Reports New Clinical and Preclinical Data at AACR-NCI-EORTC
25 Oct 2007 Seattle Genetics Reports Preclinical Data on SGN-40 and an Anti-CD19 Antibody-Drug Conjugate
25 Oct 2007 CuraGen Announces Presentation of Phase I Dose-Escalation Results on CR011- vcMMAE for Metastatic Melanoma
24 Oct 2007 ARIUS announces cancer stem cell antibody program successfully completes first toxicology study

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up